Cargando…
A Complicated Case of COVID-19-Induced Inferolateral Wall Myocardial Infarction Successfully Treated With Streptokinase
The treatment of myocardial infarction (MI) in coronavirus disease 2019 (COVID-19)-positive patients is both controversial and challenging, particularly in a healthcare setup unable to fulfill COVID-19 protocols. In this report, we describe a case of a COVID-19-positive patient admitted with COVID-1...
Autores principales: | Hussain, Taimoor, Joyce, John, Habib, Salma, Tousif, Sohaib, Ratnani, Sunny, Puvvada, Sneha |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Cureus
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8752404/ https://www.ncbi.nlm.nih.gov/pubmed/35036190 http://dx.doi.org/10.7759/cureus.20348 |
Ejemplares similares
-
A Systematic Review of the Efficacy and Safety of Tenecteplase Versus Streptokinase in the Management of Myocardial Infarction in Developing Countries
por: Muoghalu, Chioma G, et al.
Publicado: (2023) -
Incomplete myocardial rupture following inferolateral myocardial infarction
por: Kabaj, Maciej, et al.
Publicado: (2020) -
Factors Associated With Normal Flow (TIMI 3) After Thrombolysis With Streptokinase in ST-Elevation Myocardial Infarction: A Prospective Observational Study
por: Raghuram, Karthik, et al.
Publicado: (2021) -
Subacute Massive Pulmonary Embolism Treated With Streptokinase
por: Solanki, Naisargee N, et al.
Publicado: (2020) -
Thrombolysis in Myocardial Infarction (TIMI) Risk Score Assessment for Complications in Acute Anterior Wall ST Elevation Myocardial Infarction
por: Khan, Rozi, et al.
Publicado: (2020)